Takeda Pharmaceutical Company Limited Cost Of Sales
Takeda Pharmaceutical Company Limited (TKPHF) reported Cost Of Sales of JPY 1.58 trillion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2025-06-25
| Period end | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|
| 2025-03-31 | 1.58T JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 1.43T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 1.24T JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 1.11T JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 994.31B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | 1.09T JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 651.73B JPY 20-F · filed 2021-06-29 | 659.69B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 495.92B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 558.75B JPY 20-F · filed 2019-06-27 |